Loading stock data…
Azenta, Inc. (AZTA)
$30.82-0.51 (-1.63%)
After Hours$30.82+0.00 (+0.00%)· Last close Sep 8
Azenta, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Azenta, Inc. in the Healthcare sector is trading at $30.82 with a market capitalization of $1.6B. Wall Street consensus targets $35.25 (4 analysts), implying a +14.4% move over the next 12 months. The stock is currently 26% below its 52-week high of $41.73, remaining 8.8% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +14.4% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $144.79M↓ | $148.64M↓ | $158.95M↑ | $143.94M↑ | $143.34M |
| Gross Profit | $62.03M↓ | $63.71M↓ | $67.96M↑ | $67.76M↑ | $62.78M |
| Operating Income | -$15.29M↓ | -$6.09M↓ | $1.78M↑ | $40,000↑ | -$14.61M |
| Net Income | -$160.80M↓ | -$15.43M↓ | $50.84M↑ | -$52.81M↓ | -$47.66M |
Peer Comparison
JNJUNHPFE
Fundamentals
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates thro...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.64B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.38
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-8.14%
Volume
Today's trading volume
753,401
Recent News
3 Healthcare Stocks We Keep Off Our Radar
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 22.1% over the past six months while the S&P 500 was up 12.1%.
Stocks making big moves yesterday: Funko, Hims & Hers Health, Azenta, Strategy, and RUM Group
Check out the companies making headlines yesterday:
Why Azenta (AZTA) Stock Is Down Today
Shares of life sciences company Azenta (NASDAQ:AZTA) fell 9.1% in the afternoon session after the company announced, in a regulatory filing, that President and CEO John Marotta resigned from his executive roles and board seat, with current director Dr. Martin Madaus appointed as interim President and CEO.
1 Momentum Stock for Long-Term Investors and 2 We Find Risky
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro developments. As such, investors are taking notice and bidding up shares.
The 5 Most Interesting Analyst Questions From Azenta’s Q2 Earnings Call
Azenta’s second quarter showed strong momentum, with results surpassing Wall Street’s expectations for both revenue and earnings. Management attributed this outperformance to robust growth in its biorepositories and consumables and instruments (C&I) segments, which are recurring revenue businesses, alongside improved execution in Multiomics, particularly in Europe and China. CEO John Marotta highlighted, “Revenue exceeded our outlook, profitability improved sequentially and Multiomics delivered